DelveInsight has introduced a new Report on “Benign prostatic hyperplasia (BPH) Epidemiology Forecast to 2030”
DelveInsight’s ‘Benign prostatic hyperplasia (BPH) Epidemiology Forecast‘ report delivers an in-depth understanding of the disease, historical and forecasted Benign prostatic hyperplasia (BPH) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Key Highlights from report are:
Request for Sample Pages: https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-epidemiology-forecast
Benign Prostatic Hyperplasia (BPH) is a noncancerous condition in men in which the prostate gland is enlarged. BPH is also called benign prostatic hypertrophy or benign prostatic obstruction.
The prostate goes through two main growth periods as a man ages. The first occurs early in puberty when the prostate doubles in size. The second phase of growth begins around age 25 and continues during most of a man’s life. BPH often occurs with the second growth phase.
The enlarged prostate gland presses against and pinches the urethra. The bladder wall becomes thicker. Ultimately the bladder may weaken and lose the ability to empty completely. The narrowing of the urethra and urinary retention causes many of the problems associated with BPH.
Need of frequent urination is a common symptom. Other symptoms include the feeling of full bladder even after urination, a week flow of urine, stop-start urination, difficulty in starting urination, and needing to get up frequently in the night to urinate.
The cause of BPH is not well understood; however, it is most common in old men. As BPH does not develop in men whose testicles were removed before puberty, some researchers believe factors related to aging and the testicles are the underlying causes.
Researchers also believe that a high proportion of estrogen within the prostate stimulates the activity of prostate cell growth factors. Another theory suggests that dihydrotestosterone (DHT) that plays a role in prostate development and growth may be the cause as it is found that men who do not produce DHT do not develop BPH.
Request for Sample Pages: https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-market
According to the study by Lee et al., BPH is more common in older males as compared to those below 40 years.
Table of Contents
Request for Detailed TOC of the report: https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-epidemiology-forecast
Related Reports
Benign prostatic hyperplasia (BPH) – Pipeline Insights, 2020
“Benign prostatic hyperplasia (BPH) Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Benign prostatic hyperplasia (BPH) market.
Benign prostatic hyperplasia (BPH)- Market Insight, Epidemiology and Market Forecast -2030
DelveInsight’s “Benign prostatic hyperplasia (BPH) – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Benign prostatic hyperplasia (BPH), historical and forecasted epidemiology as well as the Benign prostatic hyperplasia (BPH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact us:Shruti Thakur[email protected]+91-9650213330
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/